YourWay Cannabis Brands Inc.

CNSX:YOUR Stock Report

Market Cap: CA$23.2m

YourWay Cannabis Brands Past Earnings Performance

Past criteria checks 3/6

YourWay Cannabis Brands has been growing earnings at an average annual rate of 21.1%, while the Pharmaceuticals industry saw earnings growing at 27.3% annually. Revenues have been growing at an average rate of 104.2% per year. YourWay Cannabis Brands's return on equity is 18.4%, and it has net margins of 4.5%.

Key information

21.1%

Earnings growth rate

77.9%

EPS growth rate

Pharmaceuticals Industry Growth23.1%
Revenue growth rate104.2%
Return on equity18.4%
Net Margin4.5%
Last Earnings Update30 Sep 2021

Recent past performance updates

Robust Earnings May Not Tell The Whole Story For Hollister Biosciences (CSE:HOLL)

Sep 01
Robust Earnings May Not Tell The Whole Story For Hollister Biosciences (CSE:HOLL)

Recent updates

Robust Earnings May Not Tell The Whole Story For Hollister Biosciences (CSE:HOLL)

Sep 01
Robust Earnings May Not Tell The Whole Story For Hollister Biosciences (CSE:HOLL)

Hollister Biosciences (CSE:HOLL) Shareholders Have Enjoyed An Impressive 115% Share Price Gain

Dec 28
Hollister Biosciences (CSE:HOLL) Shareholders Have Enjoyed An Impressive 115% Share Price Gain

Revenue & Expenses Breakdown

How YourWay Cannabis Brands makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CNSX:YOUR Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2167340
30 Jun 2162240
31 Mar 2153040
31 Dec 2031-440
30 Sep 2019-440
30 Jun 2010-330
31 Mar 202-420
31 Dec 191-210
31 Dec 180-100

Quality Earnings: YOUR has high quality earnings.

Growing Profit Margin: YOUR became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: YOUR has become profitable over the past 5 years, growing earnings by 21.1% per year.

Accelerating Growth: YOUR has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: YOUR has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (109.7%).


Return on Equity

High ROE: YOUR's Return on Equity (18.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies